Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Buti

Showing results (371-380 of 387) with videos related to

Pageof 39
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
The Journal of Clinical Investigation|October 1, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B StudyRui Huang, Ai-Thien Do, Hidenori Toyoda, et al.
Hepatology International|September 7, 2022
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohortYao-Chun Hsu, Dae Won Jun, Cheng-Yuan Peng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2026
Updated Global Consensus Recommendations for Risk Stratification, Treatment Initiation, and Response Monitoring in Metabolic Dysfunction-Associated Steatotic Liver DiseaseZobair M Younossi, Markos Kalligeros, Vincent Wai-Sun Wong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 19, 2026
Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 EstimatesOleksandr Korotych, Helene Høgsbro Thygesen, Otilia Mårdh, et al.
Lancet (London, England)|December 5, 2021
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortalityTom H Karlsen, Nick Sheron, Shira Zelber-Sagi, et al.
Journal of Hepatology|June 21, 2024
Sex and ethnic disparities in hepatitis B evaluation and treatment across the worldSahith Kudaravalli, Daniel Q Huang, Ming-Lun Yeh, et al.
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
Hepatology Communications|October 23, 2023
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplantGautam Mehta, Antonio Riva, Maria Pilar Ballester, et al.
Pageof 39

Showing results (371-380 of 387) with videos related to

Sort By:
Pageof 39
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
The Journal of Clinical Investigation|October 1, 2021
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortalityTomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B StudyRui Huang, Ai-Thien Do, Hidenori Toyoda, et al.
Hepatology International|September 7, 2022
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohortYao-Chun Hsu, Dae Won Jun, Cheng-Yuan Peng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 8, 2026
Updated Global Consensus Recommendations for Risk Stratification, Treatment Initiation, and Response Monitoring in Metabolic Dysfunction-Associated Steatotic Liver DiseaseZobair M Younossi, Markos Kalligeros, Vincent Wai-Sun Wong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 19, 2026
Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 EstimatesOleksandr Korotych, Helene Høgsbro Thygesen, Otilia Mårdh, et al.
Lancet (London, England)|December 5, 2021
The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortalityTom H Karlsen, Nick Sheron, Shira Zelber-Sagi, et al.
Journal of Hepatology|June 21, 2024
Sex and ethnic disparities in hepatitis B evaluation and treatment across the worldSahith Kudaravalli, Daniel Q Huang, Ming-Lun Yeh, et al.
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
Hepatology Communications|October 23, 2023
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplantGautam Mehta, Antonio Riva, Maria Pilar Ballester, et al.
Pageof 39